These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
333 related articles for article (PubMed ID: 27212693)
21. Revisiting the mammographic follow-up of BI-RADS category 3 lesions. Varas X; Leborgne JH; Leborgne F; Mezzera J; Jaumandreu S; Leborgne F AJR Am J Roentgenol; 2002 Sep; 179(3):691-5. PubMed ID: 12185047 [TBL] [Abstract][Full Text] [Related]
22. Imaging Phenotypes in Women at High Risk for Breast Cancer on Mammography, Ultrasound, and Magnetic Resonance Imaging Using the Fifth Edition of the Breast Imaging Reporting and Data System. Marino MA; Riedl CC; Bernathova M; Bernhart C; Baltzer PAT; Helbich TH; Pinker K Eur J Radiol; 2018 Sep; 106():150-159. PubMed ID: 30150038 [TBL] [Abstract][Full Text] [Related]
23. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS. Heinig J; Witteler R; Schmitz R; Kiesel L; Steinhard J Ultrasound Obstet Gynecol; 2008 Sep; 32(4):573-8. PubMed ID: 18421795 [TBL] [Abstract][Full Text] [Related]
24. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study. Aslan Ö; Oktay A; Eroğlu F Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846 [TBL] [Abstract][Full Text] [Related]
25. Dynamic contrast-enhanced MR imaging in screening detected microcalcification lesions of the breast: is there any value? Uematsu T; Yuen S; Kasami M; Uchida Y Breast Cancer Res Treat; 2007 Jul; 103(3):269-81. PubMed ID: 17063274 [TBL] [Abstract][Full Text] [Related]
26. Breast Nonmass Enhancement Detected with MRI: Uility and Lesion Characterization with Second-Look Ultrasonography. Hsu HH; Chang TH; Chou YC; Peng YJ; Ko KH; Chang WC; Lin YP; Hsu GC; Yu JC Breast J; 2015; 21(6):579-87. PubMed ID: 26390913 [TBL] [Abstract][Full Text] [Related]
27. Benign (BI-RADS 2) lesions in breast MRI. Spick C; Szolar DH; Tillich M; Reittner P; Preidler KW; Baltzer PA Clin Radiol; 2015 Apr; 70(4):395-9. PubMed ID: 25649442 [TBL] [Abstract][Full Text] [Related]
28. Surveillance of probably benign (BI-RADS 3) lesions in mammography: what is the right follow-up protocol? Buch KA; Qureshi MM; Carpentier B; Cunningham DA; Stone M; Jaffe C; Quinn M; Gonzalez C; LaVoye J; Hines N; Bloch BN Breast J; 2015; 21(2):168-74. PubMed ID: 25669425 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of the applicability of BI-RADS® MRI for the interpretation of contrast-enhanced digital mammography. Travieso-Aja MM; Maldonado-Saluzzi D; Naranjo-Santana P; Fernández-Ruiz C; Severino-Rondón W; Rodríguez Rodríguez M; Luzardo OP Radiologia (Engl Ed); 2019; 61(6):477-488. PubMed ID: 31262509 [TBL] [Abstract][Full Text] [Related]
30. Prevalence and Predictive Value of BI-RADS 3, 4, and 5 Lesions Detected on Breast MRI: Correlation with Study Indication. Chikarmane SA; Tai R; Meyer JE; Giess CS Acad Radiol; 2017 Apr; 24(4):435-441. PubMed ID: 27955878 [TBL] [Abstract][Full Text] [Related]
31. Computer-aided classification of BI-RADS category 3 breast lesions. Buchbinder SS; Leichter IS; Lederman RB; Novak B; Bamberger PN; Sklair-Levy M; Yarmish G; Fields SI Radiology; 2004 Mar; 230(3):820-3. PubMed ID: 14739315 [TBL] [Abstract][Full Text] [Related]
32. [Diagnostic value of a breast MRI score for the prediction of malignancy of breast lesions detected solely with MRI]. Siegmann KC; Moron HU; Baur A; Hahn M; Vogel U; Claussen CD; Bitzer M Rofo; 2009 Jun; 181(6):556-63. PubMed ID: 19452398 [TBL] [Abstract][Full Text] [Related]
33. Invasive lobular carcinoma of the breast: MRI pathological correlation following bilateral total mastectomy. Stivalet A; Luciani A; Pigneur F; Dao TH; Beaussart P; Merabet Z; Perlbarg J; Meyblum E; Baranes L; Calitchi E; Lepage C; Belkacemi Y; Lagrange JL; Lantieri L; Rahmouni A Acta Radiol; 2012 May; 53(4):367-75. PubMed ID: 22553225 [TBL] [Abstract][Full Text] [Related]
34. Predictive value of BI-RADS classification for breast imaging in women under age 50. Kennedy G; Markert M; Alexander JR; Avisar E Breast Cancer Res Treat; 2011 Dec; 130(3):819-23. PubMed ID: 21748292 [TBL] [Abstract][Full Text] [Related]
35. Adjunctive targeted contrast-enhanced ultrasonography for the work-up of Breast Imaging Reporting and Data System category 3 and 4 lesions. Zhang XL; Guan J; Li MZ; Liu MJ; Guo Y; Zheng YL; Yang Z; Yang JY J Med Imaging Radiat Oncol; 2016 Aug; 60(4):485-91. PubMed ID: 27162117 [TBL] [Abstract][Full Text] [Related]
36. Nonmasslike enhancement at breast MR imaging: the added value of mammography and US for lesion categorization. Thomassin-Naggara I; Trop I; Chopier J; David J; Lalonde L; Darai E; Rouzier R; Uzan S Radiology; 2011 Oct; 261(1):69-79. PubMed ID: 21771958 [TBL] [Abstract][Full Text] [Related]
37. MR imaging in probably benign lesions (BI-RADS category 3) of the breast. Gökalp G; Topal U Eur J Radiol; 2006 Mar; 57(3):436-44. PubMed ID: 16316732 [TBL] [Abstract][Full Text] [Related]
38. Can second-look ultrasound downgrade MRI-detected lesions? A retrospective study. Kolta M; Clauser P; Kapetas P; Bernathova M; Pinker K; Helbich TH; Baltzer PAT Eur J Radiol; 2020 Jun; 127():108976. PubMed ID: 32339982 [TBL] [Abstract][Full Text] [Related]
39. BI-RADS category 3, 4, and 5 lesions identified at preoperative breast MRI in patients with breast cancer: implications for management. Lee SE; Lee JH; Han K; Kim EK; Kim MJ; Moon HJ; Yoon JH; Park VY Eur Radiol; 2020 May; 30(5):2773-2781. PubMed ID: 32006168 [TBL] [Abstract][Full Text] [Related]
40. BI-RADS lexicon for US and mammography: interobserver variability and positive predictive value. Lazarus E; Mainiero MB; Schepps B; Koelliker SL; Livingston LS Radiology; 2006 May; 239(2):385-91. PubMed ID: 16569780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]